10 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... risk stratification ... schemas #Diagnosis ... #Hematology #CHADS2 ... #Anticoagulation
►
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
and bleed risk ... S Stroke 1 B Bleeding ... history/anemia ... #AFib #Diagnosis ... #Hematology
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... - HAS-BLED (atrial ... Calculators #Anticoagulation ... #Factors #Hematology ... #Diagnosis
Approach to Antithrombotic Therapy in Peripheral Artery Disease
Increased Ischemic Risk:
 • Prior MI
 • Diabetes
 •
Risk: • Anticoagulation ... • Prior bleeding ... kidney disease • Anemia ... Antithrombotic #management ... #antiplatelet #algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
patients at high risk ... of bleeding. ... risk during follow-up ... #Anticoagulation ... #Management #Hematology
Occult and Lower Gastronintestinal Bleed - Differential Diagnosis Algorithm

Occult (Stool + Occult blood and/or iron deficiency
- Differential Diagnosis ... Algorithm Occult ... iron deficiency anemia ... • Occult UGI bleeding ... Patient • RULE OUT BRISK
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... medical and surgical management ... stratification #diagnosis
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... PE - High Bleeding ... - Not High Bleeding ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... median age at diagnosis ... disease tolerate anemia ... an infection or bleeding ... #algorithm #hematology